Skip Navigation

European Journal of Echocardiography 2005 6(1):67-71; doi:10.1016/j.euje.2004.06.005
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pettersen, E.
Right arrow Articles by Vegsundvåg, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pettersen, E.
Right arrow Articles by Vegsundvåg, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, The European Society of Cardiology

Long-term echocardiographic follow-up of a patient with primary pulmonary hypertension receiving iloprost inhalations

Eirik Pettersena,*, Torstein Holm Morstølb and Johnny Aage Vegsundvågb

aDepartment of Cardiology, Rikshospitalet, 0027 Oslo
bDepartment of Internal Medicine, Ålesund Hospital, 6026 Ålesund

Received 27 January 2004; received in revised form 4 May 2004; accepted after revision 15 June 2004.

* Corresponding author. Hjertemedisinsk Avdeling, Rikshospitalet, 0027 Oslo, Norway. Tel.: +47 23074146. eirik.pettersen{at}rikshospitalet.no


   Abstract

Iloprost inhalation has recently emerged as an alternative therapy for severe primary pulmonary hypertension. In the studies documenting the effect of iloprost inhalation therapy, hemodynamic variables have been measured invasively. We have followed a patient with primary pulmonary hypertension receiving iloprost inhalation therapy for 5 years using echocardiography to monitor changes in pulmonary artery pressure and right ventricular function. Echocardiography was also used to evaluate the initial response to iloprost inhalation therapy. This case illustrates the feasibility and utility of echocardiography in the testing and follow-up of iloprost inhalation therapy in patients with pulmonary hypertension.

Keywords: Primary pulmonary hypertension; Echocardiography; Iloprost


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.